The "warfarin window" in pregnancy: the importance of half-life

Clicks: 372
ID: 111643
2010
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #1 of 2 articles by views in journal of obstetrics and gynaecology canada : jogc = journal d'obstetrique et gynecologie du canada : jogc

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Anticoagulation therapy during pregnancy in women with prosthetic cardiac valves is a therapeutic challenge. The use of vitamin K antagonists such as warfarin during pregnancy carries the potential for serious risks to the fetus, especially if these drugs are administered during the first trimester …
Reference Key
a2010journalthe Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Walfisch A;Koren G;;
Journal journal of obstetrics and gynaecology canada : jogc = journal d'obstetrique et gynecologie du canada : jogc
Year 2010
DOI
DOI not found
URL
https://www.ncbi.nlm.nih.gov/pubmed/21176310
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine pregnancy female gestational age* pregnancy complications pmid:21176310 doi:10.1016/s1701-2163(16)34689-8 asnat walfisch gideon koren anticoagulants / administration & dosage* anticoagulants / adverse effects bone and bones / drug effects bone and bones / embryology cartilage / drug effects cartilage / embryology fetal diseases / chemically induced* half-life heart valve prosthesis* heparin / administration & dosage cardiovascular / drug therapy* warfarin / administration & dosage warfarin / adverse effects* warfarin / pharmacokinetics

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.